DrugDashboards
← Home
Manufacturing facility

Direct Rx

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step β€” so if this plant has a problem, these are the products that could be affected.

Country
United States
Registered address
94 World Wide Drive Suite 110, Dawsonville, Georgia (GA) 30534, United States (USA)
Operations here
relabelrepack
FDA identifiers
FEI 3011690045 Β· DUNS 079254320

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • NAIDrug Quality Assurance2026-06-04
  • NAIDrug Quality Assurance2017-12-15
  • VAIDrug Quality Assurance2015-08-13

Drugs this plant is listed as making

323 distinct drugs across 592 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.

Direct Rx β€” facility profile Β· DrugDashboards